Press Releases
-
IgniteData secures £1/2 million Innovate UK grant for ground-breaking clinical trial data project
IgniteData has been awarded £1/2 million from Innovate UK Smart Grants to fund a transformative clinical research data project. The initiative will focus on providing hospitals and trial sponsors with streamlined access to unstructured healthcare data, delivering efficiencies, reducing costs and improving patient care. The funding will enable IgniteData to build on existing work addressing the challenges around unstructured data (such as diagnoses, clinical procedures and free text notes) and the role of Artificial Intelligence (AI) in enhancing data accessibility for clinical studies.
Mar 25, 2024
-
SIRIO launches personalised women’s health platform at Vitafoods Europe
New ready-to-launch formulation range features premium branded ingredients, and targets issues as diverse as PMS, fertility, prenatal & postnatal care and menopause wellbeing.
Mar 25, 2024
-
CluePoints’ Site Profile & Oversight Tool (SPOT) shortlisted as finalist in 2024 Citeline Awards
CluePoints, providers of best-in-class statistical and AI-driven software solutions, has been shortlisted as finalist for the Best Sponsor-facing Technology Initiative in the 2024 Citeline Awards. CluePoints was recognized for its Site Profile & Oversight Tool (SPOT), - due to launch to the market in June 2024 – and was developed collaboratively, based on market needs, with two large pharmaceutical clients of CluePoints who helped provide direction and feedback regarding the required features and functionalities.
Mar 24, 2024
-
Phastar’s Clinical Intelligence Portal Shortlisted as Finalist in 2024 Citeline Award
Phastar, a global specialist biometrics contract research organization (CRO), has been selected as finalist for the Best Sponsor-facing Technology Initiative at the Citeline Awards 2024. Phastar were recognised for the launch of their Clinical Intelligence Portal, and notably the comprehensive recruitment forecasting app within that suite.
Mar 24, 2024
-
CD Formulation Introduces Microneedle Patch Innovations for Enhanced Drug Delivery Efficiency
-
Alfa Chemistry Expands Offering of Polymer Fibers: Polyester Fiber, Polyamide Fiber, Aromatic Polyamide Fiber, and Polyacrylonitrile Fiber
-
ENPICOM secures financing from BOP Capital, BOM Brabant Ventures and brings Dr. Colby Souders on board as a new investor
Investment to bolster international partnerships and advance AI-driven solutions for antibody discovery
Mar 20, 2024
-
Alfa Chemistry’s MS and NMR Center Enables Fast, Cost-Effective Laboratory Analytical Testing
-
ReciBioPharm and GeneVentiv Therapeutics partner to advance first AAV-based gene therapy for haemophilia patients with inhibitors
ReciBioPharm and GeneVentiv Therapeutics partner to accelerate AAV-based gene therapy for haemophilia patients
Mar 19, 2024
-
CD Formulation Incorporates Phase Separation Method for Microsphere Production
-
CD Formulation Offers Accurate and Reliable Impurity Determination for Biopharmaceutical Studies
-
Alfa Chemistry Adds to Its Lineup of Derivatization Reagents for High-Performance Liquid Chromatography (HPLC)
-
Dr. Vince Clinical Research Announces First Dosing in a Phase II Study in Patients With Depression
-
Hovione and GEA Strengthen Partnership to Advance Continuous Tableting Technology
-
Don't Miss: Huateng Pharma's Exhibit at CPHI Japan 2024
Hunan Huateng Pharmaceutical Co., Ltd is set to present its groundbreaking solutions at CPHI Japan 2024, showcasing expertise in PEG derivatives and CDMO services. Attendees are encouraged to visit Booth No. 4X-08 to explore cutting-edge offerings and engage with industry experts.
Mar 18, 2024
-
Lindus Health Introduces Comprehensive “All-In-One CRO” Package for CNS, Neurology, and Psychiatric Clinical Trials
Lindus Health Introduces Comprehensive “All-In-One CRO” Package for CNS, Neurology, and Psychiatric Clinical Trials
Mar 18, 2024
-
Join Biopharma PEG Scientific Inc. at PEGS Boston Summit and TIDES USA 2024
Biopharma PEG Scientific Inc. will showcase its latest high-purity polyethylene glycol (PEG) derivatives and custom synthesis solutions at Booth No. 718 in PEGS Boston Summit 2024 and at TIDES USA 2024 at Booth No. 935.
Mar 18, 2024
-
New Syngene biologics manufacturing facility to be operational for US and European customers from mid-year
New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million vials per day
Mar 17, 2024
-
Quotient Sciences Strengthens Its Top Team with Three New Appointments
NOTTINGHAM, UK; 18 March 2024 – Drug development and manufacturing accelerator Quotient Sciences has announced major changes to its commercial and scientific executive leadership team, strengthening its position as a global leader in the sector.
Mar 18, 2024
-
SunWay Biotech and Gnosis by Lesaffre Form Alliance to Launch MenaQ7® Metabolic, featuring the ANKASCIN® 568-R ingredient